Literature DB >> 7651006

Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals.

S Vento1, L Guella, F Mirandola, F Cainelli, G Di Perri, M Solbiati, T Ferraro, E Concia.   

Abstract

During follow-up of healthy relatives of 13 patients with autoimmune hepatitis, seven cases of infectious mononucleosis due to Epstein-Barr virus (EBV) occurred. In two of these seven, before EBV infection, there was a defect in suppressor-inducer T lymphocytes specifically controlling immune responses to the asialoglycoprotein receptor, an antigen expressed on the hepatocyte surface. In these two, antibodies to this autoantigen persisted and increased after infectious mononucleosis, and autoimmune hepatitis developed within 4 months. In susceptible individuals, EBV is a trigger for autoimmune hepatitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651006     DOI: 10.1016/s0140-6736(95)91438-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

Review 1.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Vaccination-induced autoimmune hepatitis.

Authors:  Ganesh R Veerappan; Brian P Mulhall; Kent C Holtzmuller
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

3.  Autoimmune hepatitis triggered by hepatitis A.

Authors:  G Singh; S Palaniappan; O Rotimi; P J Hamlin
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 4.  Mild infectious mononucleosis presenting with transient mixed liver disease: case report with a literature review.

Authors:  David Lawee
Journal:  Can Fam Physician       Date:  2007-08       Impact factor: 3.275

5.  Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection.

Authors:  Reiichiro Kuwahara; Hiroki Saitsu; Mitsuhiko Abe; Akio Takata; Kazuo Tanaka; Teruko Hino; Tatsuya Ide; Ryoko Kuromatsu; Ken Tanikawa; Masayoshi Kage; Ryukichi Kumashiro; Michio Sata
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

Review 6.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 7.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

8.  Possible autoimmune hepatitis induced after chronic active Epstein-Barr virus infection.

Authors:  Yoshiko Wada; Chikako Sato; Kyoko Tomita; Rika Ishii-Aso; Hiroaki Haga; Kazuo Okumoto; Yuko Nishise; Hisayoshi Watanabe; Takafumi Saito; Yoshiyuki Ueno
Journal:  Clin J Gastroenterol       Date:  2013-11-23

Review 9.  Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphate.

Authors:  H Bécheur; D Valla; M A Loriot; A Attar; F Bloch; J P Petite
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Direct acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome.

Authors:  Farhad Sahebjam; Cristina H Hajdu; Esther Nortey; Samuel H Sigal
Journal:  World J Hepatol       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.